Table 5
Author | Published year | References | Inclusion criteria | Exclusion criteria |
|---|---|---|---|---|
Cai | 2011 | Cai, Wei et al. [19] | Gastric cancer Potentially resectable local tumors without distant metastatic Tumors which need to be controlled by operation against bleeding and obstruction | Patients needed thoraco-abdominal surgery Patients with other malignant tumors History of major upper abdominal surgery Gastric stump cancer Recurrent cancer ASA > III Cardiovascular risk greater than New York Heart Association grade II Severe liver disease (Child B or C) Renal dysfunction. |
Hu | 2016 | Hu, Huang et al. [22] Hu, Huang et al. [26] | Patients aged 18 to 75 years Gastric adenocarcinoma proven by endoscopic biopsy cT2-4aN0-3M0 at preoperative evaluation according to AJCC Cancer Staging Manual, 7th Edition Expected curative resection via distal subtotal gastrectomy with D2 lymphadenectomy ECOG status 0 or 1 ASA I, II, or III Written informed consent | Pregnant or breastfeeding women Severe mental disorder Previous upper abdominal surgery (except laparoscopic cholecystectomy) Previous gastrectomy, endoscopic mucosal resection, or endoscopic submucosal dissection Enlarged or bulky regional lymph node diameter larger than 3 cm based on preoperative imaging Other malignant disease within the past 5 years Previous neoadjuvant chemotherapy or radiotherapy Unstable angina, myocardial infarction, or cerebrovascular accident within the past 6 months Continuous systematic administration of corticosteroids within 1 month before the study Requirement of simultaneous surgery for other diseases Emergency surgery due to a complication (bleeding, obstruction, or perforation) caused by gastric cancer FEV1, 50% of predicted values |
Park | 2017 | Park, Yoon et al. [31] Kim, Park et al. [27] Kim, Park et al. [20] Nam, Kim et al. [21] | Patients aged 20 to 80 years Histologically proven adenocarcinoma of the stomach Clinical stage cT2-T4a cN0-3 | Participation in another trial interfering with the outcome of the present study Language problems Lack of compliance Mental inability Synchronous or previous malignant disease (except curatively treated in situ cervical cancer or curatively resected nonmelanoma skin cancer) Systemic administration of corticosteroids, Unstable angina or myocardial infarction within 6 months Severe respiratory disease ASA score > 3 Previous major abdominal surgery Previous chemo- or radiotherapy Inadequate liver, kidney, and bone-marrow functions ECOG status > 1 |
Shi | 2018 | Shi, Xu et al. [24] | Patients aged 18–80 years Gastric adenocarcinoma proven by endoscopic biopsy Preoperative cancer stage cT2-3N0-3M0 (according to AJCC-6th TNM staging) | Pregnancy ASA score > 3 Severe mental disorder Surgical history of upper abdomen (except laparoscopic cholecystectomy) Presence of other malignancies History of chemotherapy or radiation therapy Unstable angina or myocardial infarction within the past 6 months FEV1 less than 50% of predicted value Abdominal wall hernia Diaphragmatic hernia Coagulation disorder Portal hypertension |
Wang | 2018 | Wang, Xing et al. [25] | Patients age ≥ 18 years pathologically confirmed primary gastric adenocarcinoma proven by endoscopic biopsy Tumor located in the lower part of the stomach, potentially resectable by subtotal gastrectomy and D2 lymph node dissection Preoperative cancer stage cT2-4aN0-3M0 (according to AJCC-7th TNM staging) ECOG status of 0 or 1, or the American Society of Anesthesiology Classes of I, II, or III Signed informed consent | Surgical history of upper abdomen (except laparoscopic cholecystectomy) Previous gastrectomy, including endoscopic submucosal dissection and endoscopic mucosal resection Integrated or enlarged lymph node with maximum diameter larger than 3 cm according to preoperative imaging Other malignant diseases (within 5 years) Preoperative chemotherapy, immunotherapy, or radiotherapy Other illnesses needed operation concurrently Complications (bleeding, perforation, or obstruction) required emergency surgery due to primary gastric malignancy FEV1 less than 50% of predicted value Patient suffered from bleeding tendency disease such as hemophilia or took anti-coagulant medication due to deep vein thrombosis |